PATRI 发表于 2025-3-23 12:57:41

Submitted on: 15 March 2003.
Revised on: 09 June 2003.
Accepted on: 21 July 2003.

___________________Case Reports in Ophthalmological Medicine

arrogant 发表于 2025-3-23 15:26:38

Submitted on: 30 July 2010.
Revised on: 27 August 2010.
Accepted on: 17 September 2010.

___________________Case Reports in Ophthalmological Medicine

faultfinder 发表于 2025-3-23 20:23:39

Submitted on: 20 November 2009.
Revised on: 13 March 2010.
Accepted on: 13 April 2010.

___________________Case Reports in Ophthalmological Medicine

Mediocre 发表于 2025-3-23 23:05:46

http://reply.papertrans.cn/1/49/4830/4830-14.png

indenture 发表于 2025-3-24 03:27:03

http://reply.papertrans.cn/1/49/4830/4830-15.png

CRACK 发表于 2025-3-24 06:34:01

http://reply.papertrans.cn/1/49/4830/4830-16.png

观点 发表于 2025-3-24 14:16:24

http://reply.papertrans.cn/1/49/4830/4830-17.png

Chromatic 发表于 2025-3-24 15:16:10

http://reply.papertrans.cn/1/49/4830/4830-18.png

Adherent 发表于 2025-3-24 20:45:33

http://reply.papertrans.cn/1/49/4830/4830-19.png

d-limonene 发表于 2025-3-25 02:27:42

Submitted on: 10 January 2020.
Revised on: 11 March 2020.
Accepted on: 05 May 2020.

___________________Case Reports in Ophthalmological Medicine
页: 1 [2] 3 4
查看完整版本: ESCI期刊Case Reports in Ophthalmological Medicine 2024/2025影响因子:0.795 (CASE REP OPHTHAL MED) (2090-6722). (OPHTHALMOLOGY)